Presentation made by Celia Ingham Clark National Director for Reducing Premature Mortality, at Improving access to seven day services. Southampton 25 March 2015
Dr Alisha Davies explores evaluation of the 'Better access, better care, better lives' scheme in Barking, Dagenham, Redbridge and Havering as part of the Prime Minister's Challenge Fund.
Nhs innovation accelerator understanding how and why the nhs adopts innovationHugh Risebrow
Thanks Nael Clarke for highlighting Wessex AHSN report on adoption of innovation in the NHS. Innovation is difficult in any organisation, but why is it so much harder in the NHS than in say Apple, Amazon or most private businesses: My views:
1. Organisational success. In private b2c companies, success results from attracting and retaining customers through delivering innovative services which meet their needs better than competition. In the NHS, success is much more about achieving arbitrary political targets, and patients have limited choice.
2. Organisational incentives. Many innovative companies set divisional objectives around the proportion of income from new products.
3. Individual and team incentives. In successful b2c businesses, financial and career recognition/ promotion rewards are often linked to innovation. There is recognition that innovation may need a few reiterations to succeed. In the NHS, few get fired for preserving the status quo, but many lose out of they innovate and it fails first time round, and there are no individual or team incentives.
Many in the NHS seek to innovate in order to deliver better care at a lower cost. They are often faced with organisational resistance or at least inertia, and excessive bureaucracy.
Lesson 101 in management s that you get the behaviours that you incentivise. (How) should the NHS change the incentives? Is there scope for more NHS owned 'spin-outs' which allow private sector type financial incentives for staff, and greater freedom from NHS bureaucracy and governance?
Presentation made by Celia Ingham Clark National Director for Reducing Premature Mortality, at Improving access to seven day services. Southampton 25 March 2015
Dr Alisha Davies explores evaluation of the 'Better access, better care, better lives' scheme in Barking, Dagenham, Redbridge and Havering as part of the Prime Minister's Challenge Fund.
Nhs innovation accelerator understanding how and why the nhs adopts innovationHugh Risebrow
Thanks Nael Clarke for highlighting Wessex AHSN report on adoption of innovation in the NHS. Innovation is difficult in any organisation, but why is it so much harder in the NHS than in say Apple, Amazon or most private businesses: My views:
1. Organisational success. In private b2c companies, success results from attracting and retaining customers through delivering innovative services which meet their needs better than competition. In the NHS, success is much more about achieving arbitrary political targets, and patients have limited choice.
2. Organisational incentives. Many innovative companies set divisional objectives around the proportion of income from new products.
3. Individual and team incentives. In successful b2c businesses, financial and career recognition/ promotion rewards are often linked to innovation. There is recognition that innovation may need a few reiterations to succeed. In the NHS, few get fired for preserving the status quo, but many lose out of they innovate and it fails first time round, and there are no individual or team incentives.
Many in the NHS seek to innovate in order to deliver better care at a lower cost. They are often faced with organisational resistance or at least inertia, and excessive bureaucracy.
Lesson 101 in management s that you get the behaviours that you incentivise. (How) should the NHS change the incentives? Is there scope for more NHS owned 'spin-outs' which allow private sector type financial incentives for staff, and greater freedom from NHS bureaucracy and governance?
Romanian experience: regionalization, guidelines, National RDS RegistryMCH-org-ua
International conference «Actual approaches to the extremely preterm babies: International experience and Ukrainian realities» (Kyiv, Ukraine, March 5-6, 2013)
The TP-CKD Team held Cohort 2 Learning and Sharing Event - Valuing Individuals – Transforming Participation in Chronic Kidney Disease
Here are the slides from the event.
Reducing saturated fat intake for cardiovascular disease: What's the evidence? Health Evidence™
Health Evidence hosted a 60 minute webinar examining the effect of reducing saturated fat intake for cardiovascular disease. Click here for access to the audio recording for this webinar: https://youtu.be/Zwe_JF7Aqb8
Lee Hooper, Reader in Research Synthesis, Nutrition & Hydration in the Norwich Medical School at the University of East Anglia lead the session and presented findings from her latest Cochrane review:
Hooper L., Martin N., Abdelhamid A., & Smith G.D. (2015). Reduction in saturated fat intake for cardiovascular disease . Cochrane Database of Systematic Reviews, 2015, CD011737.
Public health recommendations for fat reduction and modification as prevention of cardiovascular disease have changed little over time. This Cochrane review examines the effect of reducing saturated fat intake through modification on cardiovascular morbidity and mortality through 15 randomised control trials. 17 comparisons with 59,000 participants demonstrate a 17% (RR 0.83; 95% CI 0.72 to 0.96) reduction of cardiovascular events by reducing dietary saturated fat. This webinar will examine the effect of replacing saturated fat with carbohydrate, polyunsaturated and monounsaturated fat on cardiovascular morbidity and mortality, and explore future recommendations.
Graham Lipkin, Co-chair of KQuIP and Clinical VP Renal Association, together with Ron Cullen, CEO UKRR
Presented at the Scottish Renal Association 27th - 28th October 2016
The topic was:
Kidney Quality Improvement Partnership (KQuIP) Improving care for patients with kidney disease in Scotland?
Health-related effects of government tobacco control policies: What's the evi...Health Evidence™
Health Evidence hosted a 90 minute webinar examining the effectiveness of government tobacco control policies promoted by the Framework Convention on Tobacco Control on health-related outcomes. Click here for access to the audio recording: https://youtu.be/oMBERrVazGY
Steven J. Hoffman, Director of Global Strategy Lab and Associate Professor of Law at the University of Ottawa and Charlie Tan, MD Candidate, Michael G. DeGroote School of Medicine, McMaster University, led the session and presented findings from their latest BMC Public Health review:
Hoffman SJ, & Tan C. (2015). Overview of systematic reviews on the health-related effects of government tobacco control policies. BMC Public Health, 15(744).
The global tobacco epidemic is a major public health problem that continues to deepen, with nearly 1 billion smokers worldwide in 2012. Government interventions are critical to addressing the global tobacco epidemic as it is the leading cause of preventable death, resulting in approximately 6 million unnecessary deaths per year. This review examines the effectiveness of government tobacco control policies promoted by the Framework Convention on Tobacco Control (FCTC), supporting the implementation of this international treaty on the tenth anniversary of it entering into force. This webinar highlighted factors that contribute to the effectiveness of government tobacco control policies as well as implications for practice.
Rare Diseases SA has been actively improving the quality of life for those impacted by Rare Diseases over the last 5 years.
Our key focus areas have remained advocacy, patient navigation and community engagement, and through these strategic objectives we have successfully managed to see positive impact in our community.
From the development of over 80 patient connect points, to the implementation of a mobile app, RDSA has ensured patients remain supported and connected whilst the organization remains focused on our advocacy efforts.
The successful roll-out of our Rare Assist service has also seen a reduction in out of pocket costs for patients in the private sector.
We have attached our 5 year impact report which demonstrates some of the impact our work has had within our community. We have also included our programme overview of the Rare Assist Programme.
We would love to have your feedback on these reports, as well as feedback on the following questions:
1. What interest do you have with our organisation?
2. What is your current opinion on our work?
3. How would you like to stay informed about what we do?
4. What motivates you to stay connected with us?
Should you have any questions for us, we would love to hear from you.
Kind Regards
Kelly du Plessis
CEO -Rare Diseases South Africa
info@rarediseases.co.za
UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017ipposi
Medical students taking the elective course in rare diseases are provided a number of patient perspectives throughout the module. This is what IPPOSI presented in 2017.
Martin Hefford
Sapere Research Group
(Friday, 10.00, Telehealth/mHealth)
See the related video: http://www.slideshare.net/secret/1msf1AYsNLJlSW
Congestive Heart Failure and Chronic Obstructive Pulmonary Disease are two chronic conditions that have important impacts on both the quality and length of life of individuals and on utilisation of health services. In the context of limited health funding, workforce restrictions, and an ageing population, there is increasing interest in the use of remote monitoring technologies to improve the quality of life of patients with these conditions, and to reduce unplanned use of hospital services.
In 2009 Lake Taupo Primary Health Organisation (PHO), Lakes District Health Board (DHB) and Healthcare of New Zealand Ltd, entered into a strategic partnership to pilot telehealth devices to support chronic care management in the Lake Taupo community, using a small randomised control trial approach, with ten patients in each arm. Sapere Research Group was commissioned to independently evaluate the 12 month pilot, and found good evidence that the telehealth remote monitoring technology was accepted by both Maori and non-Maori participants; that quality of life was significantly better in the telehealth group than in the control group; and some indications of a trend toward improved survival in the telehealth group. Hospitalisations were reduced in both the control (-19%) and telehealth group (-25%). Results should be considered tentative given the small numbers in the trial, but are consistent with findings of improved survival, quality of life and cost savings from recent international reviews. The impact of the telehealth intervention may have been partially masked by the simultaneous implementation of the Healthright disease management programme.
Evaluation of the TB-HIV Integration Strategy on Treatment OutcomesMEASURE Evaluation
Shared at a data dissemination and data use workshop on the results of the impact evaluation of the Strengthening Tuberculosis Control in Ukraine project. Access another presentation at https://www.slideshare.net/measureevaluation/evaluation-of-the-impact-of-a-social-support-strategy-on-treatment-outcomes/.
Colorectal screening evidence & colonoscopy screening guidelines Health Evidence™
Health Evidence hosted a 90 minute webinar examining colorectal cancer screening: benefits and harms, effective screening methods, and screening guidelines.Click here for access to the audio recording for this webinar: https://www.youtube.com/watch?v=JqOV-KHCBq8
Donna Fitzpatrick-Lewis, MSW, Senior Research Coordinator at the McMaster Evidence Review and Synthesis Centre and Dr. Maria Bacchus, Associate Professor of Medicine, Faculty of Medicine University of Calgary, and member of the Canadian Task Force on Preventive Health Care led the session. Donna presented the findings of the Synthesis Centre’s latest review and Dr. Bacchus presented findings from the Task Force’s latest guidelines:
Fitzpatrick-Lewis, D., Usman, A., Warren, R., Kenny, M., Rice, M., Bayer, A., Ciliska, D., Sherifali, D., Raina, P. Screening for colorectal cancer. Ottawa: Canadian Task Force on Preventive Health Care; 2015. Available: http://canadiantaskforce.ca/files/crc-screeningfinal2.pdf
Bacchus, C. M., Dunfield, L., Gorber, S. C., Holmes, N. M., Birtwhistle, R., Dickinson, J. A., Lewin, G., Singh, H., Klarenbach, S., Mai, V., Tonelli, M. (2016). Recommendations on screening for colorectal cancer in primary care. Canadian Medical Association Journal, cmaj-151125.
Among men and women, colorectal cancer is the second and third most common cause of cancer related death, respectively. Colorectal cancer screening guidelines, developed by the Canadian Task Force on Preventive Health Care, are based on a systematic review synthesizing evidence on the benefits and harms of screening, and the characteristics of effective screening tests. The guidelines, developed from the review, outline screening recommendations for adults aged 50 and older who are asymptomatic and not at high risk for colorectal cancer. This webinar provided a high level overview of the systematic review that informed these recommendations, followed by an overview of the recent Canadian screening guidelines.
Interventions with potential to reduce sedentary time in adults: What's the e...Health Evidence™
Health Evidence hosted a 60 minute webinar examining the effectiveness of interventions which include a sedentary behaviour outcome measure in adults. Click here for access to the audio recording for this webinar: https://youtu.be/vRKV7TnJ2R8
Anne Martin, Postdoctoral Research Associate, Physical Activity for Health Research Centre, Institute for Sport, Physical Education and Health Sciences, University of Edinburgh, and Nanette Mutrie, Professor, Director of Physical Activity for Health Research Centre, Institute for Sport, Physical Education and Health Sciences, University of Edinburgh will be leading the session and will present findings from their systematic review:
Martin A., Fitzsimons C., Jepson R., Saunders D., van der Ploeg H.P., Teixeira P.J., et al. (2015). Interventions with potential to reduce sedentary time in adults: Systematic review and meta-analysis. British Journal of Sports Medicine, 0, 1-10.
There is growing public health concern about the amount of time spent sedentary. Too much time spent in sedentary behaviours is linked with poor health, including higher cardiometabolic risk markers, type 2 diabetes and premature mortality. The primary aim of this review is to evaluate the effect of interventions which include a sedentary behaviour outcome measure in adults. 51 randomised trials (involving 18,480 participants over 18 years old) assessed the effects of interventions which included sedentary behaviour as an outcome measure in adults. There is strong evidence that it is possible to intervene to reduce sedentary behaviours in adults by 22 min/day. This webinar provided an overview of the effectiveness of interventions on sedentary behaviour in adults and explored implementation recommendations.
HCV HUB planning and implementation website introduction with a specific focus on the benefits provided to health care professionals. http://hcvhub.deusto.es
"Quality Standards to Quality Assured Indicators: The End-to-End Process", presentation delivered by John Varlow (Director of Information Services - HSCIC) and Nick Baillie (Associate Director, Indicators, Health and Social Care Quality Team, NICE), at the Healthcare Efficiency Through Technology Expo 2013.
Julie Henderson (Head of Analytical Services - HSCIC) presented with Shaun Rowark (Technical Analyst, Quality Standards - NICE) at the recent "Commissioning in Healthcare show (CiH 2015) ".
Areas covered include:
· NICE quality standards: These are concise sets of prioritised statements designed to drive measurable quality improvements within a particular area of health or care. Derived from the best available evidence, they can enable commissioners to be confident that the services they are purchasing are high quality, cost effective and focused on driving up quality.
· Real life examples of how quality standards are being used by commissioners, possible barriers to implementation and advice on how to overcome these
· Data available from the HSCIC and how to use these to support the commissioning process
Romanian experience: regionalization, guidelines, National RDS RegistryMCH-org-ua
International conference «Actual approaches to the extremely preterm babies: International experience and Ukrainian realities» (Kyiv, Ukraine, March 5-6, 2013)
The TP-CKD Team held Cohort 2 Learning and Sharing Event - Valuing Individuals – Transforming Participation in Chronic Kidney Disease
Here are the slides from the event.
Reducing saturated fat intake for cardiovascular disease: What's the evidence? Health Evidence™
Health Evidence hosted a 60 minute webinar examining the effect of reducing saturated fat intake for cardiovascular disease. Click here for access to the audio recording for this webinar: https://youtu.be/Zwe_JF7Aqb8
Lee Hooper, Reader in Research Synthesis, Nutrition & Hydration in the Norwich Medical School at the University of East Anglia lead the session and presented findings from her latest Cochrane review:
Hooper L., Martin N., Abdelhamid A., & Smith G.D. (2015). Reduction in saturated fat intake for cardiovascular disease . Cochrane Database of Systematic Reviews, 2015, CD011737.
Public health recommendations for fat reduction and modification as prevention of cardiovascular disease have changed little over time. This Cochrane review examines the effect of reducing saturated fat intake through modification on cardiovascular morbidity and mortality through 15 randomised control trials. 17 comparisons with 59,000 participants demonstrate a 17% (RR 0.83; 95% CI 0.72 to 0.96) reduction of cardiovascular events by reducing dietary saturated fat. This webinar will examine the effect of replacing saturated fat with carbohydrate, polyunsaturated and monounsaturated fat on cardiovascular morbidity and mortality, and explore future recommendations.
Graham Lipkin, Co-chair of KQuIP and Clinical VP Renal Association, together with Ron Cullen, CEO UKRR
Presented at the Scottish Renal Association 27th - 28th October 2016
The topic was:
Kidney Quality Improvement Partnership (KQuIP) Improving care for patients with kidney disease in Scotland?
Health-related effects of government tobacco control policies: What's the evi...Health Evidence™
Health Evidence hosted a 90 minute webinar examining the effectiveness of government tobacco control policies promoted by the Framework Convention on Tobacco Control on health-related outcomes. Click here for access to the audio recording: https://youtu.be/oMBERrVazGY
Steven J. Hoffman, Director of Global Strategy Lab and Associate Professor of Law at the University of Ottawa and Charlie Tan, MD Candidate, Michael G. DeGroote School of Medicine, McMaster University, led the session and presented findings from their latest BMC Public Health review:
Hoffman SJ, & Tan C. (2015). Overview of systematic reviews on the health-related effects of government tobacco control policies. BMC Public Health, 15(744).
The global tobacco epidemic is a major public health problem that continues to deepen, with nearly 1 billion smokers worldwide in 2012. Government interventions are critical to addressing the global tobacco epidemic as it is the leading cause of preventable death, resulting in approximately 6 million unnecessary deaths per year. This review examines the effectiveness of government tobacco control policies promoted by the Framework Convention on Tobacco Control (FCTC), supporting the implementation of this international treaty on the tenth anniversary of it entering into force. This webinar highlighted factors that contribute to the effectiveness of government tobacco control policies as well as implications for practice.
Rare Diseases SA has been actively improving the quality of life for those impacted by Rare Diseases over the last 5 years.
Our key focus areas have remained advocacy, patient navigation and community engagement, and through these strategic objectives we have successfully managed to see positive impact in our community.
From the development of over 80 patient connect points, to the implementation of a mobile app, RDSA has ensured patients remain supported and connected whilst the organization remains focused on our advocacy efforts.
The successful roll-out of our Rare Assist service has also seen a reduction in out of pocket costs for patients in the private sector.
We have attached our 5 year impact report which demonstrates some of the impact our work has had within our community. We have also included our programme overview of the Rare Assist Programme.
We would love to have your feedback on these reports, as well as feedback on the following questions:
1. What interest do you have with our organisation?
2. What is your current opinion on our work?
3. How would you like to stay informed about what we do?
4. What motivates you to stay connected with us?
Should you have any questions for us, we would love to hear from you.
Kind Regards
Kelly du Plessis
CEO -Rare Diseases South Africa
info@rarediseases.co.za
UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017ipposi
Medical students taking the elective course in rare diseases are provided a number of patient perspectives throughout the module. This is what IPPOSI presented in 2017.
Martin Hefford
Sapere Research Group
(Friday, 10.00, Telehealth/mHealth)
See the related video: http://www.slideshare.net/secret/1msf1AYsNLJlSW
Congestive Heart Failure and Chronic Obstructive Pulmonary Disease are two chronic conditions that have important impacts on both the quality and length of life of individuals and on utilisation of health services. In the context of limited health funding, workforce restrictions, and an ageing population, there is increasing interest in the use of remote monitoring technologies to improve the quality of life of patients with these conditions, and to reduce unplanned use of hospital services.
In 2009 Lake Taupo Primary Health Organisation (PHO), Lakes District Health Board (DHB) and Healthcare of New Zealand Ltd, entered into a strategic partnership to pilot telehealth devices to support chronic care management in the Lake Taupo community, using a small randomised control trial approach, with ten patients in each arm. Sapere Research Group was commissioned to independently evaluate the 12 month pilot, and found good evidence that the telehealth remote monitoring technology was accepted by both Maori and non-Maori participants; that quality of life was significantly better in the telehealth group than in the control group; and some indications of a trend toward improved survival in the telehealth group. Hospitalisations were reduced in both the control (-19%) and telehealth group (-25%). Results should be considered tentative given the small numbers in the trial, but are consistent with findings of improved survival, quality of life and cost savings from recent international reviews. The impact of the telehealth intervention may have been partially masked by the simultaneous implementation of the Healthright disease management programme.
Evaluation of the TB-HIV Integration Strategy on Treatment OutcomesMEASURE Evaluation
Shared at a data dissemination and data use workshop on the results of the impact evaluation of the Strengthening Tuberculosis Control in Ukraine project. Access another presentation at https://www.slideshare.net/measureevaluation/evaluation-of-the-impact-of-a-social-support-strategy-on-treatment-outcomes/.
Colorectal screening evidence & colonoscopy screening guidelines Health Evidence™
Health Evidence hosted a 90 minute webinar examining colorectal cancer screening: benefits and harms, effective screening methods, and screening guidelines.Click here for access to the audio recording for this webinar: https://www.youtube.com/watch?v=JqOV-KHCBq8
Donna Fitzpatrick-Lewis, MSW, Senior Research Coordinator at the McMaster Evidence Review and Synthesis Centre and Dr. Maria Bacchus, Associate Professor of Medicine, Faculty of Medicine University of Calgary, and member of the Canadian Task Force on Preventive Health Care led the session. Donna presented the findings of the Synthesis Centre’s latest review and Dr. Bacchus presented findings from the Task Force’s latest guidelines:
Fitzpatrick-Lewis, D., Usman, A., Warren, R., Kenny, M., Rice, M., Bayer, A., Ciliska, D., Sherifali, D., Raina, P. Screening for colorectal cancer. Ottawa: Canadian Task Force on Preventive Health Care; 2015. Available: http://canadiantaskforce.ca/files/crc-screeningfinal2.pdf
Bacchus, C. M., Dunfield, L., Gorber, S. C., Holmes, N. M., Birtwhistle, R., Dickinson, J. A., Lewin, G., Singh, H., Klarenbach, S., Mai, V., Tonelli, M. (2016). Recommendations on screening for colorectal cancer in primary care. Canadian Medical Association Journal, cmaj-151125.
Among men and women, colorectal cancer is the second and third most common cause of cancer related death, respectively. Colorectal cancer screening guidelines, developed by the Canadian Task Force on Preventive Health Care, are based on a systematic review synthesizing evidence on the benefits and harms of screening, and the characteristics of effective screening tests. The guidelines, developed from the review, outline screening recommendations for adults aged 50 and older who are asymptomatic and not at high risk for colorectal cancer. This webinar provided a high level overview of the systematic review that informed these recommendations, followed by an overview of the recent Canadian screening guidelines.
Interventions with potential to reduce sedentary time in adults: What's the e...Health Evidence™
Health Evidence hosted a 60 minute webinar examining the effectiveness of interventions which include a sedentary behaviour outcome measure in adults. Click here for access to the audio recording for this webinar: https://youtu.be/vRKV7TnJ2R8
Anne Martin, Postdoctoral Research Associate, Physical Activity for Health Research Centre, Institute for Sport, Physical Education and Health Sciences, University of Edinburgh, and Nanette Mutrie, Professor, Director of Physical Activity for Health Research Centre, Institute for Sport, Physical Education and Health Sciences, University of Edinburgh will be leading the session and will present findings from their systematic review:
Martin A., Fitzsimons C., Jepson R., Saunders D., van der Ploeg H.P., Teixeira P.J., et al. (2015). Interventions with potential to reduce sedentary time in adults: Systematic review and meta-analysis. British Journal of Sports Medicine, 0, 1-10.
There is growing public health concern about the amount of time spent sedentary. Too much time spent in sedentary behaviours is linked with poor health, including higher cardiometabolic risk markers, type 2 diabetes and premature mortality. The primary aim of this review is to evaluate the effect of interventions which include a sedentary behaviour outcome measure in adults. 51 randomised trials (involving 18,480 participants over 18 years old) assessed the effects of interventions which included sedentary behaviour as an outcome measure in adults. There is strong evidence that it is possible to intervene to reduce sedentary behaviours in adults by 22 min/day. This webinar provided an overview of the effectiveness of interventions on sedentary behaviour in adults and explored implementation recommendations.
HCV HUB planning and implementation website introduction with a specific focus on the benefits provided to health care professionals. http://hcvhub.deusto.es
"Quality Standards to Quality Assured Indicators: The End-to-End Process", presentation delivered by John Varlow (Director of Information Services - HSCIC) and Nick Baillie (Associate Director, Indicators, Health and Social Care Quality Team, NICE), at the Healthcare Efficiency Through Technology Expo 2013.
Julie Henderson (Head of Analytical Services - HSCIC) presented with Shaun Rowark (Technical Analyst, Quality Standards - NICE) at the recent "Commissioning in Healthcare show (CiH 2015) ".
Areas covered include:
· NICE quality standards: These are concise sets of prioritised statements designed to drive measurable quality improvements within a particular area of health or care. Derived from the best available evidence, they can enable commissioners to be confident that the services they are purchasing are high quality, cost effective and focused on driving up quality.
· Real life examples of how quality standards are being used by commissioners, possible barriers to implementation and advice on how to overcome these
· Data available from the HSCIC and how to use these to support the commissioning process
QI initiative: Acute Kidney Injury (AKI) Care in Acute OncologyCarl Walker
Dr Al-Sayed et al (The Christie NHS Foundation Trust) share their successful QI project to improve patient care in AKI as part of NQICAN Patient First 2016 presentation.
Improving quality, safety and lives - the Patient Safety Collaborative Programme 2014-2019
Presentation from Chief Nursing Officer for England's Summit 2014
26 November 2014
Julie Henderson (Acting Head of Clinical Services) discusses the Clinical Audit Service:
- Clinical Leadership and Engagement
- Inclusive Approach
- Audit Measurement
This presentation includes two case studies:
1) National Diabetes Audit
2) National Lung Cancer Audit
CORD Rare Drug Conference: June 8 - 9, 2022
The Ottawa Pediatric Bone Health Research Group and The Canadian Consortium for Children’s Bone Health/Canadian Alliance for Rare Disorders of the Skeleton - Leanne Ward, CHEO
Empowering and enabling charities to become trusted partners in the commissio...CharityComms
Charlie Peel, Neurological Commissioning Support
Changing the game: positioning your charity to succeed in the new health service market conference
www.charitycomms.org.uk/events
Medical and scientific advances and ethicskeshavpodanobp
Medical science is the branch of science focused on understanding how the human body works, preventing and diagnosing diseases, and finding ways to treat illnesses and injuries. It involves studying the body's systems, cells, and molecules to develop treatments that can help people live healthier lives. Medical advancements include things like new medicines, vaccines, surgical techniques, and diagnostic tools that help doctors provide better care for their patients. Overall, medical science aims to improve people's health and well-being by finding ways to prevent, diagnose, and treat diseases and injuries.
Sharing and Learning Together to Deliver High Quality End of Life Care for AllNHS Improving Quality
Sharing and Learning Together to Deliver High Quality End of Life Care for All
Presentations from the Sharing and Learning Together to Deliver High Quality End of Life Care for All event held on
Tuesday 24 June 2014, Congress Centre, London, WC1B 3LS
#nhsiqeolcare
A presentation about the British Library News Media services given by Dr Luke McKernan
Lead Curator, News and Moving Image
The British Library. 20th April 2015 for an ALISS visit.
How SCIE supports the information needs of health and social care professionalsALISS
Sue Jardine, Information Specialist, How SCIE supports the information needs of health and social care professionals
Supporting Practitioners in Health and Social Care.
ALISS conference 11th February 2015
Speedy professional conversations around learning and teaching in higher educ...ALISS
Speedy professional conversations around learning and teaching in higher education via the brand new tweetchat #LTHEchat
Sue Beckingham, Sheffield Hallam University
Chrissi Nerantzi, Manchester Metropolitan University
Peter Reed, University of Liverpool
Dr David Walker, University of Sussex
Knowledge, skills and reskilling – where does the MSc fit in?
NHS Evidence 2010
1. NHS Evidence
High quality evidence for high quality care
ALISS 14 June 2010
NHS Evidence – provided by NICE
2. NHS Evidence
Key features:
• Search
• Accredited sources of guidance
• Personalisation - My Evidence
• Browse QIPP and Specialist Collections
• Advanced healthcare databases search via
NHS Athens Resources
NHS Evidence – provided by NICE
3. Search
Search more than 150 key web sources simultaneously
including:
•Cochrane Library
•Map of Medicine
•British National Formulary
•Clinical Knowledge Summaries
•National Institute for Health and Clinical Excellence
• SCIE
NHS Evidence – provided by NICE
4. Use search for:
• Commissioning
• Clinical
• Public health
• Social care
• Drugs and technologies
• QIPP – Quality, Innovation, Productivity, Prevention
NHS Evidence – provided by NICE
5. Social care and public health
Key sources Content accessible in NHS
Evidence
SCIE – Social Care Online Policy; Guidance; Circulars, Good
Practice, Research reports
Department of Health Policy and Guidance , Information
for Commissioners, Health
Assessments
Association of Public Health Policy , Guidance, Reports, Briefings
Observatories
Health Protection Agency Guidelines, information on a large
number of infectious diseases
WHO Health Evidence Network Evidence reports
Joseph Rowntree Foundation Publications
NHS Evidence – provided by NICE
8. Use NHS Evidence search first:
• To find high quality sources, especially guidelines
and systematic reviews.
• For a quick answer - a short-cut to high quality,
free, full text resources.
• To search multiple high quality web sources
simultaneously.
NHS Evidence – provided by NICE
9. NHS Evidence search – any time, anywhere
Downloading the NHS
Evidence search bar to your
organisation‟s intranet or
website will making searching
for health and social care
information even easier.
A new version of NHS Evidence for use with
mobile phones means you can search for
health and social care information on the go.
NHS Evidence – provided by NICE
10. My Evidence - personalisation
NHS Evidence – provided by NICE
11. Manage your information better
•Saved Searches,
•Search Alerts,
•Saved Result Categories,
•News Feeds
You can also edit Your Profile
NHS Evidence – provided by NICE
12. NHS Evidence accreditation
-Overall objective of accreditation is to drive up the quality of
information used by health and social care decision makers
-Users of evidence able to easily identify and prioritise trusted
sources and have the confidence of knowing that information is of
a high standard
- Guidance producers judged against standardised criteria and
assessment processes, based on a recognised quality standard
(AGREE)
- Accreditation lasts for 3 years and allows successful
organisations to display a seal of approval – the Accreditation
Mark
Accreditation is improving the quality of processes for the leading
guidance producers
NHS Evidence – provided by NICE
13.
14. Accreditation process
Three key steps:
1. Initial submission from a guidance producer
• Is it eligible?
2. Draft accreditation decision
• Does it meet criteria?
3. Final accreditation decision
• Follows public consultation
• Final decision is published
• Accreditation mark awarded (with „from‟ „to‟ clearly
shown)
NHS Evidence – provided by NICE
15. Accreditation is raising standards
As of March 2010, the final accreditation decisions have
been made for nearly a quarter of the total number of
guidelines available on NHS Evidence.
Feedback from producers shows improvements:
• Correction of processes not being implemented in
guidance.
• Review of guidance formats to make development
processes more transparent.
• Development of new policies to remedy deficient
processes.
• Revision of existing policies to remedy deficient processes.
• Consolidation of disparate process documents into single
sources.
NHS Evidence – provided by NICE
16. Future developments for accreditation
• Building critical mass for guidance linked to areas of
greatest priority.
• New accreditation programme for other types of
information.
• Accreditation of clinical information in Clinical Decision
Support systems.
• Quality assurance of QIPP content on NHS Evidence.
• Link with NICE quality standards and QOF topics.
NHS Evidence – provided by NICE
17. QIPP
“There are lots of really powerful
examples around of things we can do to
improve quality while improving
productivity, and of how we can use
innovation to drive and embed change”.
Sir David Nicholson, NHS Chief
Executive
NHS Evidence – provided by NICE
18. QIPP background
• QIPP (Quality, Innovation, Productivity, Prevention)
collection launched by Department of Health in
December 2009
• 70 examples across the 16 topic areas
• six of the 70 highly recommended
• examples dominated by acute care and long-term
conditions
• responsibility for hosting and building collection passed
to NHS Evidence in December
NHS Evidence – provided by NICE
19. Recommended QIPP Case Study
Oxford Radcliffe Hospital
Redesign of blood transfusion using barcode
patient identification and handheld devices
Quality:
Errors and time taken to get blood to patients cut
dramatically
Productivity:
Savings overall nearly £1million a year
NHS Evidence – provided by NICE
20. Breakdown of cost benefits
Improvements in quality and efficiency include:
•reduced blood usage (£400,000 / annum)
•savings due to reduced wastage of blood (£20,000 / annum)
•reduced number of rejected samples also decreases
laboratory staff time (estimated as costing £20,000 / annum)
• wastage of consumables (£1,000 / annum)
• estimated cost savings in relation to reduced nursing time
(£500,000 / annum).
NHS Evidence – provided by NICE
21. QIPP collection on NHS Evidence
- getting involved
• Phase 2 of the development of the QIPP collection is
now underway.
• Communications push to promote participation and
usage.
• User Guide and Template are available to download:
http://www.evidence.nhs.uk/aboutus/Pages/AboutQIPP
.aspx
• Ten new case studies a month are being uploaded.
• Gaps identified and targeted
NHS Evidence – provided by NICE
22. Future developments for QIPP
• Further developments to the site.
• Health and social care interface developed.
• More public health examples.
• Mobilising case studies.
• 12 national workstreams.
NHS Evidence – provided by NICE
24. Reasons to get involved
• We must not lose our
focus on quality because
of the economic
challenges we face.
• Addressing inefficiencies
to benefit patient care is
all our responsibility.
NHS Evidence – provided by NICE
25. NHS Evidence Specialist Collections:
the original vision
Set up in 1999 with the intention that Specialist Libraries were:
• Trusted
• Relevant
• Comprehensive
• NHS led
• Easy to use
Current requirements:
• Organise specialist knowledge based upon best available evidence
• Identify and engage all key stakeholders and partners
• Identify and publish uncertainties about the effects of treatments
(DUETS)
• Promote knowledge sharing and collaboration
• Produce Annual Evidence Updates NHS Evidence – provided by NICE
26. Clinical conditions Patient groups
• Cancer • Child health
• Cardiovascular • Ethnicity and health
• Diabetes • Later life
• ENT and audiology • Learning disabilities
• Eyes and vision • Women's health
• Gastroenterology and liver
diseases Aspects of health services
• Genetic conditions • Commissioning
• Infections • Complementary and alternative
• Kidney diseases and male medicine
urogenital disorders • Emergency and urgent care
• Mental health • Health management
• Musculoskeletal • Innovation and improvement
• Neurological conditions • Public health
• Oral health • Screening
• Respiratory • Supportive and palliative care
• Skin disorders • Surgery, anaesthesia, perioperative
• Stroke and critical care
• Trauma and orthopaedics
• Vascular
NHS Evidence – provided by NICE
29. Future developments for Specialist Collections
Re-organisation of contracts under an Evidence Hub model
• Topic coverage extended. Better integration of content across
topic areas.
• Improved quality assurance and standardisation of various
outputs such as the Evidence Updates.
• More awareness services. New streamlined and standardised
Evidence Update offering.
• Greater consistency in identification of DUET uncertainties.
Transition to a new technology platform which will fundamentally
transform the way the specialist content is managed and made
available to users.
• Better integration to other NHS Evidence services such as
Search and My Evidence.
• Greater visual consistency across collections.
NHS Evidence – provided by NICE
30. NHS Athens Resources
• Access to databases, e-journals and e-books –
purchased by Strategic Health Authorities, local trusts
and local healthcare libraries in England.
• Requires an Athens username and password.
• Access limited to NHS staff in England - and certain
other small user.
NHS Evidence – provided by NICE
32. NHS Evidence indexing and abstracting
databases
1. Allied and Complementary Medicine (AMED) 1985 – date
2. British Nursing Index (BNI) 1985 – date
3. Cumulative Index of Nursing & Allied Health (CINAHL) 1981 – date
4. EMBASE 1974 – date
5. Health Business Elite
6. HMIC 1979 – date
7. MEDLINE 1950 – date
8. PsycINFO 1887 – date
NHS Evidence – provided by NICE
33. When to use NHS Evidence healthcare
databases
when you have not found the information that you need
using NHS Evidence simple search
when you need to:
• undertake a detailed search for primary references
• run a general title and abstract search across a
selection of the databases
• search for one or more databases to find work by a
particular author
• check reference details.
If you have not used these databases before it is advisable
to ask local library and knowledge service staff to assist
you. NHS Evidence – provided by NICE
34. How NHS Evidence is helping front-line staff
• NHS Evidence makes it easier to access quality-
assured, best practice information
• QIPP provides a national platform to share local best
practice.
• NHS and Social Care staff now have an easy way to
recognise the most trusted health sources of guidance
using our Accreditation Mark.
• A mobile service means staff can access information
anytime anywhere.
NHS Evidence – provided by NICE
35. “I have been impressed by the clinical integrity of the
examples of quality and productivity in action and I am
confident that they will help all staff in meeting the
challenge of delivering high quality care in a tighter
financial environment.”
Sir Bruce Keogh – NHS Medical Director
NHS Evidence – provided by NICE
36. NHS Evidence summary
Consider using it when you are searching for health
related topics in social care
• Use whenever you want to find high quality
sources notably, but not exclusively Guidelines
and Systematic Reviews
• Quick, can be a short-cut to high quality freely
available mostly full text web based resources.
• Use when you want to broaden your range of
sources
• Remember that it is a developing resource and
that you can contribute to its development
NHS Evidence – provided by NICE
37. Get involved
• Enquiries team - contactable by phone, email or online
form
• Focus groups
• Public consultations
• External advisers on the NHS Evidence accreditation
programme.
• Advisory panels for sources of content.
contactus@evidence.nhs.uk or call 0845 003 77 44NHS Evidence – provided by NICE